Filing Details
BIO-TECHNE Corp (NASDAQ:TECH) filed a Form 8-K with the Securities and Exchange Commission on June 25, 2026, disclosing a material event.
8k filedNASDAQ:TECH
BIO-TECHNE Corp (TECH) Reports Material Event to SEC
Filing Details BIO-TECHNE Corp (NASDAQ:TECH) filed a Form 8-K with the Securities and Exchange Commission on June 25, 2026, disclosing a material event. Market Context BIO-TECHNE…
Market Context
BIO-TECHNE Corp's stock currently trades at $70.70 with a market capitalization of $9.4B. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for BIO-TECHNE Corp's stock.
All SEC filings for BIO-TECHNE Corp are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View TECH Stock Page
Frequently Asked Questions
Where can I read TECH's SEC filings?
Browse all filings on our TECH SEC filings page.
What types of SEC filings does BIO-TECHNE Corp file?
Public companies like BIO-TECHNE Corp file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
